20/20 Biolabs Inc.
- AIDX
- NASDAQ
- Medical - Care Facilities
- Cancer Screening Tests
- Clinical Laboratory Testing
$0.26
Today −0.12%Quote Oct 19, 2026, 08:00 PM UTC
−44.03%over the last month
Max drawdown −44.7%From 1-month high −44.7%3 months −52.5%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About 20/20 Biolabs
20/20 GeneSystems, Inc. operates as a clinical laboratory testing company focused on cancer screening and viral testing services. The company provides multi-cancer early detection blood testing, including a test called OneTest, and offers viral testing services such as rapid COVID-19 test kits, including the Assure COVID-19 IgG/IgM rapid test.
Sector
Healthcare
Industry
Medical - Care Facilities
Exchange
NASDAQ
Employees
14
Founded
2000
Market value
$2.8M
Quote Oct 19
Analyst target
$5.00
+1820.9% from here
Floor
$0.22
17.3% below price
Resistance
$0.31
17.6% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about AIDXPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free